132260-16-3

Basic information

• Product Name: 1-C-(hydroxymethyl)-1-deamino-1-nitro-3,2',6',3''-tetrakis-N-(tert-butoxycarbonyl)kanamycin B
• Synonyms: 1-C-(hydroxymethyl)-1-deamino-1-nitro-3,2',6',3''-tetrakis-N-(tert-butoxycarbonyl)kanamycin B
• CAS NO: 132260-16-3
• Molecular Weight: 943.998
• Mol File: 132260-16-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-C-(hydroxymethyl)-1-deamino-1-nitro-3,2',6',3''-tetrakis-N-(tert-butoxycarbonyl)kanamycin B(CAS DataBase Reference)
• NIST Chemistry Reference: 1-C-(hydroxymethyl)-1-deamino-1-nitro-3,2',6',3''-tetrakis-N-(tert-butoxycarbonyl)kanamycin B(132260-16-3)
• EPA Substance Registry System: 1-C-(hydroxymethyl)-1-deamino-1-nitro-3,2',6',3''-tetrakis-N-(tert-butoxycarbonyl)kanamycin B(132260-16-3)

Safety Data

• Hazardous Substances Data: 132260-16-3(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 4696-76-8 kananmycin B 
• 132260-11-8 1-N-<(benzyloxy)carbonyl>-3,2',6'-tris-N-(tert-butoxycarbonyl)-3''-N-(trifluoroacetyl)kanamycin B 
• 132260-13-0 1-N-<(benzyloxy)carbonyl>-3,2',6',3''-tetrakis-N-(tert-butoxycarbonyl)kanamycin B 
• 132260-12-9 1-N-<(benzyloxy)carbonyl>-3,2',6'-tris-N-(tert-butoxycarbonyl)kanamycin B 
• 132260-10-7 3,2',6'-tris-N-(tert-butoxycarbonyl)-3''-N-(trifluoroacetyl)kanamycin B 
• 132260-14-1 3,2',6',3''-tetrakis-N-(tert-butoxycarbonyl)kanamycin B 
• 132260-09-4 3,2',6'-tris-N-(tert-butoxycarbonyl)kanamycin B 
• 50-00-0 formaldehyd 
• 132260-15-2 1-deamino-1-nitro-3,2',6',3''-tetrakis-N-(tert-butoxycarbonyl)kanamycin B 

Downstream Products

• 132260-18-5 1-C-(hydroxymethyl)kanamycin B 
• 132260-17-4 1-C-(hydroxymethyl)-3,2',6',3''-tetrakis-N-(tert-butoxycarbonyl)kanamycin B 

Relevant articles and documents

New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6″. Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation

Substitution of the C-1 atom in the 2-deoxystreptamine moiety of gentamicin C2, a broad-spectrum aminoglycoside antibiotic, by an axial hydroxymethyl group has been reported to confer protection against most clinically important bacterial enzym